Nicholas Jene

Loss of <i><scp>CDKN</scp>2A</i> expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the <scp>CDK</scp>4/6 inhibitor <scp>PD</scp>0332991 in melanoma cell lines

Richard J. Young, Kelly Waldeck, Claire Martin et al. · Pigment Cell & Melanoma Research · 2014 · 207 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers

Max Yan, Nicholas Jene, David J. Byrne et al. · Breast Cancer Research · 2011 · 175 citations · Full text

Life Sciences, Immunology, Oncology +17

Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas

Siddhartha Deb, Nicholas Jene, kConFab Investigators et al. · BMC Cancer · 2012 · 68 citations · Full text

Medicine, Genetics, Oncology +14

PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer

Siddhartha Deb, Hongdo Do, David J. Byrne et al. · Breast Cancer Research · 2013 · 30 citations · Full text

Veterinary Medicine, Genetics, Oncology +13

Methylation profiling of ductal carcinoma in situand its relationship to histopathological features

Jia‐Min Pang, Siddhartha Deb, Elena A. Takano et al. · Breast Cancer Research · 2014 · 27 citations · Full text

Medicine, Molecular Biology, Oncology +17